Study led by Dr. Tariq Salam, 2020

Safety and effectiveness of a novel fluoroless transseptal puncture technique for lead-free catheter ablation: A case series

Faster, zero-fluoroscopy transseptal puncture (TSP) time*

The NRG™ Transseptal Needle offered a faster, fluoroless transseptal puncture technique for catheter ablation compared to a mechanical needle.*


Key takeaways

Achieved single or double TSP 100% successfully without fluoroscopy within 28±15 min

Observed total procedure time of 135±34 minutes without any significant complications

Faster, fluoroless transseptal time

In this retrospective study of 382 cases, the RF NRG Transseptal Needle enabled zero-fluoroscopy transseptal access via first TSP within 27.8±15.1 min of initial venous access.1 This is comparable to times seen with fluoroscopy-guided RF transseptal puncture, which showed improvement relative to the use of conventional mechanical needles with fluoroscopy (36.4±17.7 min).*, 2

The RF NRG Transseptal Needle enabled a faster and fluoroless transseptal puncture time.

100% TSP success rate

Using the dedicated RF NRG Transseptal Needle, single and double TSP were achieved with 100% success without any fluoroscopy, regardless of septal anatomy or history of prior transseptal catheterization.

Using the RF NRG Transseptal Needle technique, 100% of attempted TSP were achieved successfully without any fluoroscopy.

 Transseptal reimagined.

Physician’s perspective

Tariq Salam, MD, discusses his publication which analyzed the safety and effectiveness of fluoroless TSP using the NRG Transseptal Needle


Products in this study

NRG Transseptal Needle.

NRGTM Transseptal Needle


References:

  1. Salam, T., et al. (2020). Safety and effectiveness of a novel fluoroless transseptal puncture technique for lead-free catheter ablation: A case series. J Innov Card Rhythm Manag, 11(4), 4079-4085. doi: 10.19102/icrm.2020.110405
  2. Winkle, R.A., et al. (2011). The use of a radiofrequency needle improves the safety and efficacy of transseptal puncture for atrial fibrillation ablation. Heart Rhythm, 8(9), 1411–1415. doi: 10.1016/j.hrthm.2011.04.032

* Based on use of NRG Transseptal Needle from femoral to left atrial access compared to previously published data using mechanical needle. Not head-to-head comparison.

All trademarks are the property of their respective owners.


CAUTION: The law restricts these devices to sale by or on the order of a physician. Indications, contraindications, warnings, and instructions for use can be found in the product labelling supplied with each device or at www.IFU-BSCI.com. Products shown for INFORMATION purposes only and may not be approved or for sale in certain countries. This material not intended for use in France.